Reynolds Cameron John — SEC Form 4 filings
SEC reporting owner CIK 1340610. 16 Form 4 filings on record with FilingPulse; latest filed 2026-02-27.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-26 to 2026-02-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 8 filings — 577,254 shares, $319,087 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 181,818 shares @ $0.55 ($100,000) in VOLITIONRX LTD, filed 2025-03-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VOLITIONRX LTD (VNRX) | President and CEO, Director | 16 | 8 legs · 577,254 sh · $319,087 | — | 10 |
Form 4 filings — Reynolds Cameron John
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-27 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 486,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 74,700 @ $0 | EDGAR |
| 2025-11-17 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 20,000 @ $0.35 | EDGAR |
| 2025-10-15 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 110,000 @ $0.51 · Purchase (P): 110,000 (derivative) @ $0.01 | EDGAR |
| 2025-09-15 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 15,000 @ $0.66 | EDGAR |
| 2025-08-06 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 78,125 @ $0.64 | EDGAR |
| 2025-07-25 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2025-06-16 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 12,500 @ $0.59 | EDGAR |
| 2025-05-19 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 20,000 @ $0.44 | EDGAR |
| 2025-03-27 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 181,818 @ $0.55 | EDGAR |
| 2025-01-31 | 4 | VOLITIONRX LTD (VNRX) | Disposition to issuer (D): 50,000 (derivative) · Grant/award (A): 50,000 (derivative) | EDGAR |
| 2024-12-10 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 139,811 @ $0.57 | EDGAR |
| 2024-09-04 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 103,243 @ $0 | EDGAR |
| 2024-08-16 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 29,500 @ $0 | EDGAR |
| 2024-06-04 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 90,182 @ $0 | EDGAR |
| 2024-01-26 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 50,150 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1340610 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →